These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9562619)

  • 1. Identification of lipid inhibitor of mammalian phospholipase D.
    Kawabe K; Kodaki T; Katayama K; Okamura S; Mori M; Yamashita S
    J Biochem; 1998 May; 123(5):870-5. PubMed ID: 9562619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of rat brain phospholipase D by lysophospholipids.
    Ryu SB; Palta JP
    J Lipid Res; 2000 Jun; 41(6):940-4. PubMed ID: 10828086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phospholipase D by a protein factor from bovine brain cytosol. Partial purification and characterization of the inhibition mechanism.
    Kim JH; Suh YJ; Lee TG; Kim Y; Bae SS; Kim MJ; Lambeth JD; Suh PG; Ryu SH
    J Biol Chem; 1996 Oct; 271(41):25213-9. PubMed ID: 8810281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple forms of phospholipase D inhibitor from rat brain cytosol. Purification and characterization of heat-labile form.
    Han JS; Chung JK; Kang HS; Donaldson J; Bae YS; Rhee SG
    J Biol Chem; 1996 May; 271(19):11163-9. PubMed ID: 8626662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota.
    Mwanjewe J; Spitaler M; Ebner M; Windegger M; Geiger M; Kampfer S; Hofmann J; Uberall F; Grunicke HH
    Biochem J; 2001 Oct; 359(Pt 1):211-7. PubMed ID: 11563985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced levels of oleate-dependent and Arf-dependent phospholipase D isoforms in experimental colon cancer.
    Yoshida M; Okamura S; Kodaki T; Mori M; Yamashita S
    Oncol Res; 1998; 10(8):399-406. PubMed ID: 10100756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosylation factor 1-regulated phospholipase D activity is localized at the plasma membrane and intracellular organelles in HL60 cells.
    Whatmore J; Morgan CP; Cunningham E; Collison KS; Willison KR; Cockcroft S
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):785-94. PubMed ID: 9003363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.
    Jenco JM; Rawlingson A; Daniels B; Morris AJ
    Biochemistry; 1998 Apr; 37(14):4901-9. PubMed ID: 9538008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism.
    Burgdorf C; Schäfer U; Richardt G; Kurz T
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):555-9. PubMed ID: 20179606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes.
    Sciorra VA; Rudge SA; Prestwich GD; Frohman MA; Engebrecht J; Morris AJ
    EMBO J; 1999 Nov; 18(21):5911-21. PubMed ID: 10545103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling by phospholipase D as a therapeutic target.
    Steed PM; Chow AH
    Curr Pharm Biotechnol; 2001 Sep; 2(3):241-56. PubMed ID: 11530878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct inhibition of in vitro PLD activity by 4-(2-aminoethyl)-benzenesulfonyl fluoride.
    Andrews B; Bond K; Lehman JA; Horn JM; Dugan A; Gomez-Cambronero J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):302-11. PubMed ID: 10873602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of protein kinase A increases phospholipase D activity and inhibits phospholipase D activation by acetylcholine in tracheal smooth muscle.
    Mamoon AM; Smith J; Baker RC; Farley JM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1188-95. PubMed ID: 10565841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A soluble protein negatively regulates phospholipase D activity. Partial purification and characterization.
    Geny B; Paris S; Dubois T; Franco M; Lukowski S; Chardin P; Russo Marie F
    Eur J Biochem; 1995 Jul; 231(1):31-9. PubMed ID: 7628481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes.
    Scott SA; Spencer CT; O'Reilly MC; Brown KA; Lavieri RR; Cho CH; Jung DI; Larock RC; Brown HA; Lindsley CW
    ACS Chem Biol; 2015 Feb; 10(2):421-32. PubMed ID: 25384256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.
    Kim JH; Lee BD; Kim Y; Lee SD; Suh PG; Ryu SH
    J Immunol; 1999 Nov; 163(10):5462-70. PubMed ID: 10553072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells.
    Vitale N; Caumont AS; Chasserot-Golaz S; Du G; Wu S; Sciorra VA; Morris AJ; Frohman MA; Bader MF
    EMBO J; 2001 May; 20(10):2424-34. PubMed ID: 11350931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phospholipase D by amphiphysins.
    Lee C; Kim SR; Chung JK; Frohman MA; Kilimann MW; Rhee SG
    J Biol Chem; 2000 Jun; 275(25):18751-8. PubMed ID: 10764771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel, Ca(2+)-dependent phospholipase D with preference for phosphatidylserine and phosphatidylethanolamine in Saccharomyces cerevisiae.
    Mayr JA; Kohlwein SD; Paltauf F
    FEBS Lett; 1996 Sep; 393(2-3):236-40. PubMed ID: 8814297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.